My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

HUTCHMED (China) Limited - American Depositary Shares (NQ:HCM)

11.99 -0.05 (-0.42%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HUTCHMED (China) Limited - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Week In Review: Insilico Closes $255 Million Round For AI Drug Discovery/Development ↗

June 26, 2021

Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. The company is developing its own products and...

Via Talk Markets

Topics Artificial Intelligence

45 Biggest Movers From Yesterday ↗

June 24, 2021

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 23, 2021

Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of...

Via Benzinga

31 Stocks Moving In Wednesday's Mid-Day Session ↗

June 23, 2021

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 21, 2021

Gainers Adial Pharmaceuticals (NASDAQ:ADIL

Via Benzinga

Week In Review: This Week's China Life Science Deals Total Over $2.5 Billion ↗

June 19, 2021

Shanghai's Zai Lab announced a four-drug immunonocology deal with MacroGenics worth over $1.4 billion. Shanghai's HutchMed (formerly Hutchison Chi-Med) is planning to raise $600 million in a Hong...

Via Talk Markets

Hutchmed Files For Over $600M Hong Kong IPO ↗

June 18, 2021

Hutchmed (China) Limited (NASDAQ: HCM) will look to raise $603 million as part of a Hong Kong IPO, listed in the U.S., since 2016. The company plans to offer up to 104...

Via Benzinga

Topics Initial Public Offering

Week In Review: Shanghai CARsgen To Raise $400 Million In Hong Kong IPO ↗

June 12, 2021

Shanghai CARsgen Therapeutics is staging an IPO on the Hong Kong Exchange that could raise $400 million to support development of the company's CAR-T portfolio. The shares are scheduled to begin...

Via Talk Markets

Topics Initial Public Offering

Week In Review: Sorrento Acquires ACEA In $488 Million Deal Between Two San Diego-China Oncology Biopharmas ↗

April 10, 2021

Sorrento Therapeutics will acquire ACEA Therapeutics in a deal worth up to $488 million. Both companies develop novel cancer drugs, both are headquartered in San Diego and both have operations in...

Via Talk Markets

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.